Progress for hearing preservation trial after Australian approval granted
Approval has been granted by the Australian authorities to allow a French company to progress…
01/07/2022 - 3 minutes
Liza Laws
Companies come together in fight against Dengue Fever
A vaccine to treat dengue fever, the mosquito-borne disease, is the end goal of two…
01/07/2022 - 4 minutes
License submitted to FDA for drug to help those with large B-cell lymphoma
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
01/07/2022 - 3 minutes
LG Chem renews license triggering $2M payment to Avacta
South Korean clinical stage biopharmaceutical company, LG Chem Life Sciences, has triggered a license renewal…
30/06/2022 - 2 minutes
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
30/06/2022 - 3 minutes
Funding doubled for company working on breakthrough auto-immune disease therapeutics
A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it…
30/06/2022 - 3 minutes
Global call for scientists and inventors to form new startup
A fourth start-up but the first of its kind sees some high-profile companies join forces…
29/06/2022 - 3 minutes
Drug for childhood arthritis gets expanded approvals in the EU
A drug that can reduce the risk of flare and disease activity in children with…
29/06/2022 - 4 minutes
Encouraging results from respiratory diseases vaccine trial
A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with…
29/06/2022 - 4 minutes
Deal to advance treatment for autoimmune disease worth $97M
MiroBio, which is developing checkpoint agonists to treat autoimmune disease, has announced the completion of…
29/06/2022 - 2 minutes
Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
28/06/2022 - 2 minutes
Breast cancer drug recommended for approval
A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of…
28/06/2022 - 3 minutes
